Selective targeting of microbes by peptides of the innate immune system.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cytolytic antimicrobial peptides (AMPs) are key components of the innate immune system of many organisms including man. They act by disrupting the outer membranes of bacteria, fungi and enveloped viruses. These simple peptides are highly specific and increasingly seen as a new source of antibiotic agents capable of combating the rising resistance to current drugs. Our aim is to determine the mechanism by which cytolytic AMPs act and to understand the factors that give rise to membrane and cell specificity.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $626,644.00

Funder: National Health and Medical Research Council